Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.
Spathis AD, Asvos X, Ziavra D, Karampelas T, Topouzis S, Cournia Z, Qing X, Alexakos P, Smits LM, Dalla C, Rideout HJ, Schwamborn JC, Tamvakopoulos C, Fokas D, Vassilatis DK. Spathis AD, et al. Among authors: alexakos p. Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3999-4004. doi: 10.1073/pnas.1616874114. Epub 2017 Mar 27. Proc Natl Acad Sci U S A. 2017. PMID: 28348207 Free PMC article.
Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice.
Argyrofthalmidou M, Spathis AD, Maniati M, Poula A, Katsianou MA, Sotiriou E, Manousaki M, Perier C, Papapanagiotou I, Papadopoulou-Daifoti Z, Pitychoutis PM, Alexakos P, Vila M, Stefanis L, Vassilatis DK. Argyrofthalmidou M, et al. Among authors: alexakos p. Hum Mol Genet. 2021 Jul 28;30(16):1469-1483. doi: 10.1093/hmg/ddab118. Hum Mol Genet. 2021. PMID: 33902111 Free PMC article.
Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.
Nikolaou PE, Boengler K, Efentakis P, Vouvogiannopoulou K, Zoga A, Gaboriaud-Kolar N, Myrianthopoulos V, Alexakos P, Kostomitsopoulos N, Rerras I, Tsantili-Kakoulidou A, Skaltsounis AL, Papapetropoulos A, Iliodromitis EK, Schulz R, Andreadou I. Nikolaou PE, et al. Among authors: alexakos p. Cardiovasc Res. 2019 Jun 1;115(7):1228-1243. doi: 10.1093/cvr/cvz061. Cardiovasc Res. 2019. PMID: 30843027
Growing male rats in individually ventilated and open-top cages.
Kostomitsopoulos N, Dontas IA, Alexakos P, Lelovas P, Galanos A, Paronis E, Balafas E, Paschidis K, Kostakis A. Kostomitsopoulos N, et al. Among authors: alexakos p. J Am Assoc Lab Anim Sci. 2011 Nov;50(6):879-83. J Am Assoc Lab Anim Sci. 2011. PMID: 22330780 Free PMC article.
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial.
Voskaridou E, Christoulas D, Konstantinidou M, Tsiftsakis E, Alexakos P, Terpos E. Voskaridou E, et al. Among authors: alexakos p. Haematologica. 2008 Oct;93(10):1588-90. doi: 10.3324/haematol.12849. Epub 2008 Aug 12. Haematologica. 2008. PMID: 18698086 Free article. Clinical Trial. No abstract available.
11 results